Valuation: Orgenesis Inc.

Market Cap 983K 865K 804K 738K 1.39M 94.9M 1.41M 9.54M 3.73M 46.52M 3.69M 3.61M 161M P/E 2023
-0.26x
P/E 2024 -0.17x
Enterprise Value 19.16M 16.86M 15.67M 14.39M 27.01M 1.85B 27.46M 186M 72.68M 907M 71.94M 70.39M 3.14B EV / Sales 2023
71.2x
EV / Sales 2024 27x
Free-Float
52.06%
Yield 2023 *
-
Yield 2024 -
1 week+9,423.81%
3 months-30.43%
6 months+110.53%
Current year+166.67%
1 week 0.04
Extreme 0.04
0.4
1 month 0
Extreme 0.001
0.45
Current year 0
Extreme 0.001
0.84
1 year 0
Extreme 0.0001
1
3 years 0
Extreme 0.0001
11.7
5 years 0
Extreme 0.0001
54.9
10 years 0
Extreme 0.0001
168
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 72 02/02/2012
Chief Executive Officer 57 24/12/2013
Director of Finance/CFO 51 10/03/2026
Director TitleAgeSince
Chairman 57 14/08/2014
Director/Board Member 64 08/07/2024
Director/Board Member 47 28/10/2024
Date Insider Type Main position Quantity % Market Cap.
5/3/25 Other 1,200,000 23.2142%
12/12/24 Free

Director

1,875 0.0363%
12/12/24 Free

Director

1,750 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+9,423.81%-60.00%-96.19% 3.92M
+2.29%+2.36%-18.56%-8.74% 180B
+1.46%+0.01%-10.47%-6.46% 107B
+1.58%+0.65%+6.73%+61.49% 60.29B
-1.13%-2.60%+26.37%+54.76% 50.19B
+2.22%-1.14%-15.63%-44.81% 43.08B
+2.98%-2.61% - - 32.77B
+1.50%-6.67%-19.61%-44.95% 27.61B
-7.67%-8.39%+24.55%-12.97% 23.1B
+1.63%-1.73%-7.11%-8.13% 20.86B
Average +0.49%+3,987.99%-8.19%-11.78% 54.39B
Weighted average by Cap. +1.28%-0.11%-6.87%+1.09%

Financials

2023 2024
Net sales 530K 466K 433K 398K 747K 51.18M 759K 5.15M 2.01M 25.08M 1.99M 1.95M 86.81M 1.03M 911K 846K 777K 1.46M 99.94M 1.48M 10.05M 3.93M 48.99M 3.89M 3.8M 170M
Net income -55.36M -48.71M -45.27M -41.57M -78.01M -5.35B -79.33M -538M -210M -2.62B -208M -203M -9.07B -48.16M -42.38M -39.38M -36.16M -67.87M -4.65B -69.01M -468M -183M -2.28B -181M -177M -7.89B
Net Debt 21.78M 19.17M 17.81M 16.36M 30.7M 2.1B 31.21M 212M 82.62M 1.03B 81.77M 80.01M 3.57B 18.18M 16M 14.87M 13.65M 25.62M 1.76B 26.05M 177M 68.95M 861M 68.25M 66.78M 2.98B
Logo Orgenesis Inc.
Orgenesis Inc. is a biotech company focused on cell and gene therapies (CGTs). The Company focuses on the development of autologous therapies that can be manufactured under processes and systems that are developed for each therapy using a closed and automated approach that is validated for compliant production near the patient for treatment of the patient at the point of care. It operates in two segments: Octomera LLC (Octomera segment) and therapies related activities (Therapies segment). The Octomera segment includes mainly point of care (POCare) services. The Therapies segment includes the Company’s therapeutic development operations. The POCare Services platform is utilized by parties, such as biotech companies and hospitals for the supply of their products. Octomera’s services include adapting the process to the platform and supplying the products; adaptation of automation and closed systems to serviced therapies, and contract research organization services for clinical trials.
Employees
77
Date Price Change Volume
23/07/26 US$0.4000 0.00% 200
21/07/26 US$0.4000 0.00% 200
20/07/26 US$0.4000 +9,423.81% 101
17/07/26 US$0.004200 +320.00% 1,010
  1. Stock Market
  2. Stocks
  3. ORGS Stock